167 related articles for article (PubMed ID: 36180571)
1. Ubiquitin-specific protease 3 facilitates cell proliferation by deubiquitinating pyruvate kinase L/R in gallbladder cancer.
Liang RP; Zhang XX; Zhao J; Zhu RT; Wang WJ; Lu QW; Sun YL
Lab Invest; 2022 Dec; 102(12):1367-1376. PubMed ID: 36180571
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA FOXP1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin-specific protease 3 promotes cell migration and invasion by interacting with and deubiquitinating SUZ12 in gastric cancer.
Wu X; Liu M; Zhu H; Wang J; Dai W; Li J; Zhu D; Tang W; Xiao Y; Lin J; Zhang W; Sun Y; Zhang Y; Chen Y; Li G; Li A; Xiang L; Liu S; Wang J
J Exp Clin Cancer Res; 2019 Jun; 38(1):277. PubMed ID: 31234902
[TBL] [Abstract][Full Text] [Related]
4. USP3 promotes breast cancer cell proliferation by deubiquitinating KLF5.
Wu Y; Qin J; Li F; Yang C; Li Z; Zhou Z; Zhang H; Li Y; Wang X; Liu R; Tao Q; Chen W; Chen C
J Biol Chem; 2019 Nov; 294(47):17837-17847. PubMed ID: 31624151
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin-specific protease 3 overexpression promotes gastric carcinogenesis and is predictive of poor patient prognosis.
Fang CL; Lin CC; Chen HK; Hseu YC; Hung ST; Sun DP; Uen YH; Lin KY
Cancer Sci; 2018 Nov; 109(11):3438-3449. PubMed ID: 30168892
[TBL] [Abstract][Full Text] [Related]
6. USP3 counteracts RNF168 via deubiquitinating H2A and γH2AX at lysine 13 and 15.
Sharma N; Zhu Q; Wani G; He J; Wang QE; Wani AA
Cell Cycle; 2014; 13(1):106-14. PubMed ID: 24196443
[TBL] [Abstract][Full Text] [Related]
7. USP3 promotes gastric cancer progression and metastasis by deubiquitination-dependent COL9A3/COL6A5 stabilisation.
Wu X; Wang H; Zhu D; Chai Y; Wang J; Dai W; Xiao Y; Tang W; Li J; Hong L; Pei M; Zhang J; Lin Z; Wang J; Li A; Liu S
Cell Death Dis; 2021 Dec; 13(1):10. PubMed ID: 34930901
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed microRNA-136 works as a cancer suppressor in gallbladder cancer through suppression of JNK signaling pathway via inhibition of MAP2K4.
Niu J; Li Z; Li F
Am J Physiol Gastrointest Liver Physiol; 2019 Nov; 317(5):G670-G681. PubMed ID: 31369289
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme USP3 controls CHK1 chromatin association and activation.
Cheng YC; Shieh SY
Proc Natl Acad Sci U S A; 2018 May; 115(21):5546-5551. PubMed ID: 29735693
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin overexpression predicts poor prognosis and promotes cell proliferation and invasion through ERK pathway activation in gallbladder cancer.
Cao Y; Liang H; Zhang F; Luan Z; Zhao S; Wang XA; Liu S; Bao R; Shu Y; Ma Q; Zhu J; Liu Y
J Exp Clin Cancer Res; 2016 Apr; 35():68. PubMed ID: 27084680
[TBL] [Abstract][Full Text] [Related]
11. Protein deubiquitylase USP3 stabilizes Aurora A to promote proliferation and metastasis of esophageal squamous cell carcinoma.
Shi K; Zhang JZ; Yang L; Li NN; Yue Y; Du XH; Zhang XZ; Lu YC; Guo D
BMC Cancer; 2021 Nov; 21(1):1196. PubMed ID: 34758762
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitin-specific protease 3 targets TRAF6 for deubiquitination and suppresses IL-1β induced chondrocyte apoptosis.
Zhou Q; Xiao Z; Zhou R; Zhou Y; Fu P; Li X; Wu Y; Wu H; Qian Q
Biochem Biophys Res Commun; 2019 Jun; 514(2):482-489. PubMed ID: 31056254
[TBL] [Abstract][Full Text] [Related]
13. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas9-based genome-wide screening of the deubiquitinase subfamily identifies USP3 as a protein stabilizer of REST blocking neuronal differentiation and promotes neuroblastoma tumorigenesis.
Karapurkar JK; Kim MS; Colaco JC; Suresh B; Sarodaya N; Kim DH; Park CH; Hong SH; Kim KS; Ramakrishna S
J Exp Clin Cancer Res; 2023 May; 42(1):121. PubMed ID: 37170124
[TBL] [Abstract][Full Text] [Related]
15. USP3 stabilizes p53 protein through its deubiquitinase activity.
Fu S; Shao S; Wang L; Liu H; Hou H; Wang Y; Wang H; Huang X; Lv R
Biochem Biophys Res Commun; 2017 Oct; 492(2):178-183. PubMed ID: 28807825
[TBL] [Abstract][Full Text] [Related]
16. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K/AKT signaling pathway.
Li A; Wang S; Nie J; Xiao S; Xie X; Zhang Y; Tong W; Yao G; Liu N; Dan F; Shu Z; Liu J; Liu Z; Yang F
Cell Death Dis; 2024 Mar; 15(3):235. PubMed ID: 38531846
[TBL] [Abstract][Full Text] [Related]
17. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
Yang L; Gao Q; Wu X; Feng F; Xu K
J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
20. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
